Inflammation- t-PA synthesis

Recombinant biotechnology has allowed tissue plasminogen activator (tPA) to be manufactured in the lab. It is classified as a serine protease which is one of the essential components for the dissolution of blood clots. In vivo which of the following cells is the main source of plasma tissue-type plasminogen activator (t-PA)?